Simple Reason for Hypoglycemia: ACE Inhibitor-induced Severe Recurrent Hypoglycemia in a Nondiabetic Patient
Name:
1567006969-20190828-204-9cytkh.pdf
Size:
3.659Mb
Format:
PDF
Description:
Final Published Version
Affiliation
Univ Arizona, Coll Med Phoenix, Endocrinol Diabet & MetabIssue Date
2019-08-21
Metadata
Show full item recordPublisher
CUREUS INCCitation
Elshimy G, Techathaveewat P, Alsayed M, et al. (August 21, 2019) Simple Reason for Hypoglycemia: ACE Inhibitor-induced Severe Recurrent Hypoglycemia in a Nondiabetic Patient. Cureus 11(8): e5449. doi:10.7759/cureus.5449Journal
CUREUSRights
© Copyright 2019 Elshimy et al. This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 3.0.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Angiotensin-converting enzyme (ACE) inhibitors are among the most common medications used to treat patients with concomitant diabetes and hypertension. They are considered the first line of treatment for hypertension in this population. Several case studies have reported that ACE inhibitors can induce hypoglycemia in patients with diabetes. To our knowledge, however, ACE inhibitors have not been found to induce hypoglycemia in patients without diabetes. This report describes a patient without diabetes experiencing recurrent severe hypoglycemia induced by the ACE inhibitor lisinopril.Note
Open access journalISSN
2168-8184PubMed ID
31489273Version
Final published versionae974a485f413a2113503eed53cd6c53
10.7759/cureus.5449
Scopus Count
Collections
Except where otherwise noted, this item's license is described as © Copyright 2019 Elshimy et al. This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 3.0.
Related articles
- ACE inhibitor use is associated with hospitalization for severe hypoglycemia in patients with diabetes. DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside, Scotland. Medicines Monitoring Unit.
- Authors: Morris AD, Boyle DI, McMahon AD, Pearce H, Evans JM, Newton RW, Jung RT, MacDonald TM
- Issue date: 1997 Sep
- An Unexpected Case of Lisinopril-Associated Severe Hyponatremia.
- Authors: Jiang Y, Cai W, Masquelin ME, Gordon K
- Issue date: 2020 Jul 7
- Angiotensin-converting enzyme insertion/deletion polymorphism and severe hypoglycemia complicating type 2 diabetes: the Fremantle Diabetes Study.
- Authors: Davis WA, Brown SG, Jacobs IG, Bulsara M, Beilby J, Bruce DG, Davis TM
- Issue date: 2011 Apr
- The impact of the angiotensin-converting enzyme insertion/deletion polymorphism on severe hypoglycemia in Type 2 diabetes.
- Authors: Freathy RM, Lonnen KF, Steele AM, Minton JA, Frayling TM, Hattersley AT, Macleod KM
- Issue date: 2006 Summer
- Overview of the angiotensin-converting-enzyme inhibitors.
- Authors: Piepho RW
- Issue date: 2000 Oct 1

